Age (years), median (range) |
39 (24 – 81) |
40 (23 – 81) |
0.94 |
BMI (kg/m2), median (range) |
23.1 (19.3 –
31.6) |
24.2 (18.0 – 41.0) |
0.27 |
History of abdominal surgery |
19 (31,1) |
33 (31,7) |
1.00 |
ASA scorea |
60 |
104 |
0.22 |
1
|
44 (73.3)
|
86 (82.7)
|
|
≥2
|
16 (26.7)
|
18 (17.3)
|
|
FIGO stage |
|
|
1.00b
|
IA1 and IA2
|
4 (6.6)
|
7 (6.7)
|
|
IB1 and IIA
|
57(93.4)
|
97 (93.3)
|
|
Histology |
|
|
0.58 |
Squamous cell
|
41 (67.2)
|
71 (68.3)
|
|
Adenocarcinoma
|
17 (27.9)
|
24 (23.1)
|
|
Other (adenosquamous, clearcell, villoglandular)
|
3 (4.9)
|
9 (8.7)
|
|
Grade c
|
60 |
102 |
0.26 |
I
|
10 (16.7)
|
27 (26.5)
|
|
II
|
36 (60.0)
|
49 (48.0)
|
|
III
|
14 (23.3)
|
26 (25.5)
|
|
Type of procedure |
|
|
0.38 |
PLND and RH
|
43 (70.5)
|
59 (56.7)
|
|
PLND and RVT
|
8 (13.1)
|
20 (19.2)
|
|
PLND only
|
4 (6.6)
|
9 (8.7)
|
|
Otherd
|
6 (9.8)
|
16 (15.4)
|
|
SN procedure performed |
53 (86.9) |
92 (88.5) |
0.96 |
LN harvested (excluding SN only), median (range) |
27 (12-56) |
24 (10-61) |
0.31 |
LN harvested (excluding SN only) |
|
|
|
<17 lymph nodes harvestede
|
2 (3.3)
|
11 (11.0)
|
0.13b
|
≥17 lymph nodes harvested
|
58 (96.7)
|
89 (89.0)
|
|
Positive LN status |
7 (11.5) |
14 (13.5) |
0.90 |
Positive LVSI |
28 (45.9) |
47 (46.1) |
1.00 |
Positive parametrial involvement |
4 (6.6) |
4 (3.8) |
0.47b
|
Adjuvant or adjusted treatment |
15 (24.6) |
20 (19.2) |
0.54 |
Radiotherapy
|
10 (16.4)
|
8 (7.7)
|
0.22
|
Chemoradiation
|
5 (8.2)
|
12 (11.5)
|
|
Follow up duration (months), median (range) |
62 (14-132) |
43
(3-91) |
<0.001f
|